Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) Target Price at $35.40
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) has been given a consensus recommendation of “Buy” by the eight ratings firms that are currently covering the firm, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price […]
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) has been given a consensus recommendation of “Buy” by the eight ratings firms that are currently covering the firm, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price […]
